Commission Implementing Regulation (EU) 2023/1107 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘Manorapid express’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)
Articolo 1
In vigore · versione del 27 giu 2023
A Union authorisation with authorisation number EU-0027674-0000 is granted to Lysoform Dr. Hans Rosemann GmbH for the making available on the market and use of the same single biocidal product ‘Manorapid express’ in accordance with the summary of the biocidal product characteristics set out in the Annex.
The Union authorisation is valid from 27 June 2023 until 31 July 2032.